Glycemic variability in relation to oral disposition index in the subjects with different stages of glucose tolerance

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Chen, Tong ^a   Xu, Feng ^a   Su, Jian Bin ^a   Wang, Xue Qin ^a   Chen, Jin Feng ^a   Wu, Gang ^a   Jin, Yan ^a   Wang, Xiao Hua ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Continuous glucose monitoring; Glycemic variability; Oral disposition index; Type 2 diabetes

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE VARIABILITY; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; ORAL DISPOSITION INDEX; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL;

EID: 84880334842     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-38     Document Type: Article

References (35)

1. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Abdul-Ghani MA, Williams K, DeFronzo R, Stern M, Diabetes Care 2006 29 1613 1618 10.2337/dc05-1711 16801587 (Pubitemid 44127589)
2. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Abdul-Ghani MA, Tripathy D, DeFronzo RA, Diabetes Care 2006 29 1130 1139 10.2337/dc05-2179 16644654 (Pubitemid 44115261)
3. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test. Festa A, Williams K, Hanley AJ, Haffner SM, Diabetes 2008 57 1638 1644 10.2337/db07-0954 18332099
4. What is the best predictor of future type 2 diabetes? Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M, Diabetes Care 2007 30 1544 1548 10.2337/dc06-1331 17384342 (Pubitemid 46871168)
5. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Renn W, Gerich J, Diabetes Care 2000 23 295 301 10.2337/diacare.23.3.295 10868854 (Pubitemid 30131733)
6. Glucose response curve and type 2 diabetes risk in Latino adolescents. Kim JY, Coletta DK, Mandarino LJ, Shaibi GQ, Diabetes Care 2012 35 1925 1930 10.2337/dc11-2476 22751962
7. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C, JAMA 2006 295 1681 1687 10.1001/jama.295.14.1681 16609090
8. Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Torimoto K, Okada Y, Mori H, Tanaka Y, Cardiovasc Diabetol 2013 12 1 10.1186/1475-2840-12-1 23280391
9. Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes. Sartore G, Chilelli NC, Burlina S, Lapolla A, Acta Diabetol 2013 50 437 442 10.1007/s00592-013-0459-9 23417155
10. Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, Wolpert H, Endocrine Society, J Clin Endocrinol Metab 2011 96 2968 2979 10.1210/jc.2010-2756 21976745
11. Chinese clinical guideline for continuous glucose monitoring (2012). Chinese Diabetes Society, Chin Med J (Engl) 2012 125 4167 4174
12. Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Hill NR, Oliver NS, Choudhary P, Levy JC, Hindmarsh P, Matthews DR, Diabetes Technol Ther 2011 13 921 928 10.1089/dia.2010.0247 21714681
13. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2011 34 62 S69 21193628
14. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Matsuda M, DeFronzo RA, Diabetes Care 1999 22 1462 1470 10.2337/diacare.22.9.1462 10480510 (Pubitemid 29418240)
15. Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese. Oka R, Yagi K, Sakurai M, Nakamura K, Moriuchi T, Miyamoto S, Nohara A, Kawashiri MA, Takeda Y, Yamagishi M, Endocr J 2012 59 55 64 10.1507/endocrj.EJ11-0157 22068110
16. A novel approach to continuous glucose analysis utilizing glycemic variation. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ, Diabetes Technol Ther 2005 7 253 263 10.1089/dia.2005.7.253 15857227 (Pubitemid 40586369)
17. Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. Kovatchev BP, Cox DJ, Kumar A, Gonder-Frederick L, Clarke WL, Diabetes Technol Ther 2003 5 817 828 10.1089/152091503322527021 14633347 (Pubitemid 37339544)
18. Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability. Molnar GD, Taylor WF, Ho MM, Diabetologia 1972 8 342 348 10.1007/BF01218495 4641791
19. Mean amplitude of glycemic excursions, a measure of diabetic instability. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF, Diabetes 1970 19 644 655 5469118
20. Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring. Zhou J, Li H, Ran X, Yang W, Li Q, Peng Y, Li Y, Gao X, Luan X, Wang W, Jia W, Med Sci Monit 2011 17 R9 CR13 10.12659/MSM.881318 21169911
21. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Utzschneider KM, Prigeon RL, Faulenbach MV, Tong J, Carr DB, Boyko EJ, Leonetti DL, McNeely MJ, Fujimoto WY, Kahn SE, Diabetes Care 2009 32 335 341 18957530
22. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK, Zinman B, Obesity (Silver Spring) 2008 16 8 1901 1907 10.1038/oby.2008.307
23. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? Monnier L, Colette C, Owens DR, J Diabetes Sci Technol 2008 2 1094 1100 19885298
24. Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study. Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witte DR, ADAG Study Group, Diabetologia 2010 53 1608 1611 10.1007/s00125-010-1741-9 20396998
25. Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus. Wang C, Lv L, Yang Y, Chen D, Liu G, Chen L, Song Y, He L, Li X, Tian H, Jia W, Ran X, Clin Endocrinol (Oxf) 2012 76 810 815 10.1111/j.1365-2265.2011.04205.x
26. Sources of glycemic variability-what type of technology is needed? Kildegaard J, Christensen TF, Hejlesen OK, J Diabetes Sci Technol 2009 3 986 991 20144350
27. Evaluation of the mean absolute glucose change as a measure of glycemic variability using continuous glucose monitoring data. Kohnert KD, Heinke P, Fritzsche G, Vogt L, Augstein P, Salzsieder E, Diabetes Technol Ther 2013 15 448 454 10.1089/dia.2012.0303 23550553
28. New and improved methods to characterize glycemic variability using continuous glucose monitoring. Rodbard D, Diabetes Technol Ther 2009 11 551 565 10.1089/dia.2009.0015 19764834
29. Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Rodbard D, Bailey T, Jovanovic L, Zisser H, Kaplan R, Garg SK, Diabetes Technol Ther 2009 11 717 723 10.1089/dia.2009.0077 19905888
30. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Rodbard D, Diabetes Technol Ther 2009 11 55 S67 19469679
31. The use of a computer program to calculate the mean amplitude of glycemic excursions. Fritzsche G, Kohnert KD, Heinke P, Vogt L, Salzsieder E, Diabetes Technol Ther 2011 13 319 325 10.1089/dia.2010.0108 21291337
32. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Pratley RE, Weyer C, Diabetologia 2001 44 929 945 10.1007/s001250100580 11484070 (Pubitemid 32778125)
33. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Fukushima M, Suzuki H, Seino Y, Diabetes Res Clin Pract 2004 66 37 S43 15563978
34. Loss of early insulin secretion leads to postprandial hyperglycaemia. Del Prato S, Diabetologia 2003 46 2 M8 12652352
35. Orchestration of glucose homeostasis: from a small acorn to the California oak. Bergman RN, Diabetes 2007 56 1489 1501 10.2337/db07-9903 17526912 (Pubitemid 46842592)